In the webinar Winlow talks about the US P3 trials that were also successful. If those results were so successful why haven't the regulators legalised the supervised use of MDMA to treat PTSD in the US? We all know the major SP catalyst for biotechs is FDA approval, but there is no chance of that for at least 5 years according to Winlow. There is also no suggestion from other regulators that they will legalise MDMA use. My guess is that's why the share prices hasn't moved much off these good results.
- Forums
- ASX - By Stock
- Ann: Hidden Gems Webinar Presentation
EMD
emyria limited
Add to My Watchlist
3.57%
!
2.7¢

In the webinar Winlow talks about the US P3 trials that were...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.7¢ |
Change
-0.001(3.57%) |
Mkt cap ! $16.50M |
Open | High | Low | Value | Volume |
2.7¢ | 2.8¢ | 2.6¢ | $29.59K | 1.096M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4919 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 1363075 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4919 | 0.027 |
8 | 779237 | 0.026 |
6 | 2284601 | 0.025 |
7 | 930497 | 0.024 |
11 | 908695 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 1363075 | 5 |
0.029 | 690000 | 4 |
0.030 | 147104 | 3 |
0.031 | 94812 | 1 |
0.032 | 92000 | 1 |
Last trade - 13.02pm 01/07/2025 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Dr. Hartley Atkinson, MD
Dr. Hartley Atkinson
MD
Previous Video
Next Video
SPONSORED BY The Market Online